PsychoGenics has also pioneered the translation of rodent behavioral responses into robust, high-throughput, high content phenotyping and its drug discovery platforms, SmartCube, NeuroCube and PhenoCube have led to shared risk partnerships with companies such as Sunovion and Roche and has resulted in the discovery of several novel compounds in clinical trials or advanced preclinical development.
PsychoGenics
PsychoGenics is a premier preclinical contract research organization (CRO) focused on central nervous system (CNS) disorders and translational neuroscience. Utilizing automated behavioral testing platforms, advanced AI data analytics, and robust animal disease models, PsychoGenics accelerates the discovery of novel treatments for psychiatric, cognitive, and neurodegenerative conditions.
